Robert L. Stolfi - Concepedia

Author

Robert L. Stolfi

Also Known As

R L Stolfi, R STOLFI, R Stolfi, R. L Stolfi, R. L. STOLFI, R. L. Stolfi, R. Stolfi, R.L. Stolfi, Robert L Stolfi, Robert L. Stolfi

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Catholic Medical Center Memorial Sloan Kettering Cancer Center Columbia University

About

Robert L. Stolfi is an author at Catholic Medical Center specializing in medicine, pharmacology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	36	1.2K
2	Natural Sciences	5	5	287
3	Health Sciences	3	3	140
4	Allergy	3	3	149
5	Engineering	1	1	27

Robert L. Stolfi

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Improving the anti-tumor activity of 5-fluorouracil by increasing its incorporation into RNA via metabolic modulation. S. Spiegelman, Robert C. Sawyer, R. Nayak, Proceedings of the National Academy of Sciences Chemoprevention StrategyTumor BiologyAnti-cancer AgentAnti-tumor ActivityThymidine Triphosphate	1980	119
Immune Lytic Transformation: A State of Irreversible Damage Generated as a Result of the Reaction of the Eighth Component in the Guinea Pig Complement System Robert L. Stolfi The Journal of Immunology Low Osmotic PressureHumoral ResponseImmunologyAntigen ProcessingImmune System	1968	112
High-dose 5-fluorouracil with delayed uridine "rescue" in mice. Daniel Martín, Robert L. Stolfi, Robert C. Sawyer, PubMed OncologyHealth SciencesDelayed UridinePharmacological StudyMedicine	1982	103
Potentiation of the anti-tumor activity of 5FU by thymidine and its correlation with the formation of (5FU) RNA S. Spiegelman, R. Nayak, Robert C. Sawyer, Cancer Antitumor ActivityMolecular BiologyCancer BiologyTumor BiologyMedicinal Chemistry	1980	79
Therapeutic utility of utilizing low doses of N-(phosphonacetyl)-L-aspartic acid in combination with 5-fluorouracil: a murine study with clinical relevance. Daniel Martín, Robert L. Stolfi, Robert C. Sawyer, PubMed OncologyChemoprevention StrategyTherapeutic UtilityPharmacologyClinical Relevance	1983	74
Modulation of 5-fluorouracil-induced toxicity in mice with interferon or with the interferon inducer, polyinosinic-polycytidylic acid. Robert L. Stolfi, Daniel Martín, Robert C. Sawyer, PubMed InflammationMolecular PharmacologyMouse InterferonInterferon InducerImmunotoxicology	1983	51
Incorporation of 5-fluorouracil into murine bone marrow DNA in vivo. Robert C. Sawyer, Robert L. Stolfi, Daniel Martín, PubMed Tumor BiologyOncologyRadiation TherapyBiochemistryTritium Radioactivity	1984	46
Coordinate inhibition of plasminogen activator and tumor growth by hydrocortisone in mouse mammary carcinoma. Rafael Mira-y-Lopez, E. Reich, Robert L. Stolfi, PubMed ImmunologyUrokinase TypeCancer BiologyTumor BiologyPlasminogen Activator	1985	42
Comparison of adjuvant chemotherapeutic activity against primary and metastatic spontaneous murine tumors. Ruth A. Fugmann, Joan C. Anderson, Robert L. Stolfi, PubMed Tumor BiologyMetastatic Tumor IncidenceSurgical OncologyBreast OncologyMedicine	1977	41
Biochemical modulation of 5-fluorouracil with leucovorin or delayed uridine rescue L. Dee Nord, Robert L. Stolfi, Daniel S. Martin Biochemical Pharmacology Medicinal ChemistryPharmaceutical ScienceBiochemical ModulationBiochemistryNatural Sciences	1992	39

Page 1